Continuous ambulatory peritoneal dialysis: three-year experience at one center

Area of Science:

• Nephrology
• Internal Medicine
• Clinical Research

Background:

• Continuous ambulatory peritoneal dialysis (CAPD) is a vital treatment for end-stage renal disease.
• Long-term clinical data are essential for understanding CAPD's efficacy and challenges.

Purpose of the Study:

• To summarize three years of clinical experience with CAPD.
• To evaluate the long-term effects and complications of CAPD.

Main Methods:

• Clinical data from patients undergoing CAPD for three years were reviewed.
• Key biochemical markers (serum urea nitrogen, creatinine, electrolytes, etc.) and clinical outcomes were assessed.

Main Results:

• Most biochemical markers remained within acceptable ranges.
• Peritonitis incidence decreased with improved solutions and adapters but remains a concern.
• Potential long-term issues include excessive carbohydrate absorption, obesity, and high serum triglycerides.

Conclusions:

• CAPD demonstrates effectiveness in maintaining biochemical stability over three years.
• Ongoing challenges with peritonitis and metabolic complications require continued attention and management strategies.